Inactive Instrument

diaDexus, Inc. Stock OTC Bulletin Board

Pharmaceuticals

End-of-day quote OTC Bulletin Board
- ^USD	-

17/09/21	Diadexus, Inc. Went Out of Business	CI
08/06/18	Motion for Asset Sale Approved for Diadexus, Inc.	CI

Diadexus, Inc. is a diagnostics company. The Company is engaged in developing and commercializing products that deliver healthcare providers with relevant information to assist in the management of patients throughout the course of cardiac disease. Its capabilities include manufacturing, assay development, Food and Drug Administration (FDA) regulatory clearance, and marketing and selling products. Its commercially-available products consist of two FDA-cleared tests to measure Lp-PLA2: the PLAC Test ELISA Kit (the PLAC ELISA Test) and the PLAC Test for Lp-PLA2 Activity (the PLAC Activity Test). Its other products include proADM; proET-1, which aids in predication of heart failure, and proANP, which aids in predication of heart failure. The Company sells its diagnostic products to laboratories and promotes these products to the laboratories' sales representatives, as well as directly to healthcare providers.

Employees

Sector

Pharmaceuticals

More about the company

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	49.2K 44.04K 41.06K 37.24K 70.24K 4.7M 70.68K 493K 193K 2.43M 185K 181K 7.81M	P/E 2014	-3.26x	P/E 2015	-1.14x
Enterprise Value	5.29M 4.74M 4.41M 4M 7.55M 506M 7.6M 53.05M 20.77M 261M 19.87M 19.43M 840M	EV / Sales 2014	1.05x	EV / Sales 2015	0.77x
Free-Float	100%	Yield 2014 *	-	Yield 2015	-

17/09/21	Diadexus, Inc. Went Out of Business	CI
08/06/18	Motion for Asset Sale Approved for Diadexus, Inc.	CI
09/05/18	Motion for Asset Sale Filed by Diadexus, Inc.	CI
01/08/16	Diazyme Laboratories, Inc. completed the acquisition of operational assets from Diadexus, Inc. (OTCPK:DDXS.Q).	CI
29/07/16	Motion for Asset Sale Approved for Diadexus, Inc.	CI
29/07/16	General Atomics Corp. entered into purchase agreement to acquire operational assets from Diadexus, Inc. (OTCPK:DDXS.Q) for $4.8 million.	CI
20/07/16	Cleveland HeartLab, Inc. cancelled the acquisition of operational assets from Diadexus, Inc. (OTCPK:DDXS.Q).	CI
07/07/16	Motion for Asset Sale Filed by Diadexus, Inc.	CI
07/07/16	Cleveland HeartLab, Inc. agreed to acquire operational assets from Diadexus, Inc. (OTCPK:DDXS.Q) for $7 million.	CI
13/06/16	Diadexus, Inc. Filed for Bankruptcy	CI
11/06/16	Diadexus, Inc. Announces Resignation of Leone Patterson as Chief Financial Office	CI
23/05/16	Diadexus, Sonic Healthcare USA Sign National Agreement for PLAC Activity Test	CI
30/04/16	Diadexus, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2016	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+0.28%	+3.46%	+44.33%	+93.71%	1,051B
JOHNSON & JOHNSON	+0.88%	+4.27%	+38.15%	+68.70%	630B
ABBVIE INC.	+1.68%	+5.78%	+22.07%	+89.56%	489B
MERCK & CO., INC.	-0.10%	+4.24%	+69.72%	+40.41%	359B
ROCHE HOLDING AG	+0.61%	+4.14%	+24.05%	+41.70%	344B
NOVARTIS AG	+0.72%	+3.11%	+14.29%	+33.76%	272B
ASTRAZENECA PLC	+0.23%	+1.31%	-5.91%	+9.89%	246B
AMGEN INC.	+0.65%	+3.62%	+42.81%	+46.50%	224B
GILEAD SCIENCES, INC.	-0.49%	+4.01%	+27.26%	+95.97%	187B
Average	+0.33%	+2.86%	+30.75%	+57.80%	422.63B
Weighted average by Cap.	+0.41%	+2.93%	+34.67%	+66.90%

	2014	2015
Net sales	26.11M 23.38M 21.79M 19.76M 37.28M 2.5B 37.51M 262M 103M 1.29B 98.09M 95.91M 4.15B	17.88M 16.01M 14.92M 13.54M 25.53M 1.71B 25.69M 179M 70.21M 882M 67.18M 65.69M 2.84B
Net income	-8.47M -7.58M -7.07M -6.41M -12.09M -809M -12.16M -84.91M -33.24M -418M -31.81M -31.1M -1.34B	-7.17M -6.42M -5.98M -5.42M -10.23M -685M -10.29M -71.87M -28.13M -353M -26.92M -26.32M -1.14B
Net Debt	-198K -177K -165K -150K -283K -18.93M -284K -1.99M -777K -9.77M -744K -727K -31.43M	5.24M 4.69M 4.37M 3.97M 7.48M 501M 7.53M 52.56M 20.58M 259M 19.69M 19.25M 832M

diaDexus, Inc. Stock OTC Bulletin Board

Stocks

Pharmaceuticals

Valuation: diaDexus, Inc.

Latest news: diaDexus, Inc.

Diagnostic & Testing Substances Manufacturers

Financials

Company Profile